Immunohistochemical analysis of T-cell subsets in the peribulbar and intrabulbar infiltrates of alopecia areata.

PubWeight™: 1.13‹?› | Rank: Top 10%

🔗 View Article (PMID 6203277)

Published in Acta Derm Venereol on January 01, 1984

Authors

C Perret, L Wiesner-Menzel, R Happle

Articles citing this

Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest (1998) 1.27

What causes alopecia areata? Exp Dermatol (2013) 1.14

Topical immunotherapy changes the composition of the peribulbar infiltrate in alopecia areata. Arch Dermatol Res (1986) 1.00

Single nucleotide polymorphisms in the promoter regions of Foxp3 and ICOSLG genes are associated with Alopecia areata. Clin Exp Med (2012) 0.96

Heat treatment increases the incidence of alopecia areata in the C3H/HeJ mouse model. Cell Stress Chaperones (2010) 0.89

Cytokines and growth factors influence hair growth in vitro. Possible implications for the pathogenesis and treatment of alopecia areata. Arch Dermatol Res (1996) 0.86

Diphencyprone induced vitiligo: a case report. Case Rep Med (2012) 0.79

Characterization of psoriasiform and alopecic skin lesions in HLA-B27 transgenic rats. Am J Pathol (1995) 0.77

Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata. Clin Exp Immunol (2004) 0.76

Breeding and preliminarily phenotyping of a congenic mouse model with alopecia areata. Dongwuxue Yanjiu (2014) 0.76

Angiotensin converting enzyme activity in alopecia areata. Enzyme Res (2014) 0.75

Recombinant human hepatitis B vaccine initiating alopecia areata: testing the hypothesis using the C3H/HeJ mouse model. Vet Dermatol (2009) 0.75

The role of lymphocytes in the development and treatment of alopecia areata. Expert Rev Clin Immunol (2015) 0.75

Articles by these authors

Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A (1998) 4.99

The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol (1999) 4.06

Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat Genet (1996) 3.56

Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin. J Am Acad Dermatol (1987) 3.40

Intensive care physicians' insufficient knowledge of right-heart catheterization at the bedside: time to act? Crit Care Med (1997) 3.09

Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation. Am J Med Genet (1999) 3.02

Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene. Oncogene (2001) 2.63

What every dermatologist should know about homeopathy. Arch Dermatol (1996) 2.59

Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trial. Ann Intern Med (1994) 2.45

Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. Oncogene (2001) 2.25

Is the pulmonary artery catheter misused? A European view. Crit Care Med (1998) 2.23

Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas. Proc Natl Acad Sci U S A (2004) 2.03

The McCune-Albright syndrome: a lethal gene surviving by mosaicism. Clin Genet (1986) 1.98

Lyonization and the lines of Blaschko. Hum Genet (1985) 1.86

Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas. Oncogene (2006) 1.84

Cytokine mRNA levels in Alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. J Invest Dermatol (1994) 1.76

Superimposed lateralized exanthem of childhood: report of a case related to adenovirus infection. Clin Exp Dermatol (2014) 1.73

Induction of hair growth in alopecia areata with D.N.C.B. Lancet (1977) 1.66

Type 2 segmental Cowden disease vs. Proteus syndrome. Br J Dermatol (2007) 1.63

Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin. Cancer Res (2001) 1.63

Cutaneous manifestation of lethal genes. Hum Genet (1986) 1.59

Treatment of alopecia areata with diphenylcyclopropenone. J Am Acad Dermatol (1991) 1.56

Cutis marmorata telangiectatica congenita and extensive mongolian spots: type 5 phacomatosis pigmentovascularis. Br J Dermatol (2003) 1.56

Segmental forms of autosomal dominant skin disorders: different types of severity reflect different states of zygosity. Am J Med Genet (1996) 1.54

Psoriasis vulgaris, fetal growth, and genomic imprinting. Am J Med Genet (1992) 1.49

Mutations in the NSDHL gene, encoding a 3beta-hydroxysteroid dehydrogenase, cause CHILD syndrome. Am J Med Genet (2000) 1.48

Mechanical controlled hypoventilation in status asthmaticus. Am Rev Respir Dis (1984) 1.48

Main characteristics of the hindlimb locomotor cycle in the decorticate cat with special reference to bifunctional muscles. Brain Res (1980) 1.42

[What is a hamartoma?]. Ann Dermatol Venereol (1998) 1.39

The CHILD syndrome. Congenital hemidysplasia with ichthyosiform erythroderma and limb defects. Eur J Pediatr (1980) 1.36

An unusual case of porokeratosis involving the natal cleft: porokeratosis ptychotropica? Br J Dermatol (1995) 1.36

A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer. J Med Genet (2002) 1.35

Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus. Br J Dermatol (1983) 1.35

Permissive hypercapnia. How permissive should we be? Am J Respir Crit Care Med (1994) 1.35

Phacomatosis pigmentokeratotica: a melanocytic-epidermal twin nevus syndrome. Am J Med Genet (1996) 1.32

Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated beta-catenin. Cancer Res (1999) 1.29

N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study. Chest (1994) 1.27

[Epidemic listeriosis. Report of 25 cases in 15 months at the Vaud University Hospital Center]. Schweiz Med Wochenschr (1985) 1.25

Overexpression of regenerating islet-derived 1 alpha and 3 alpha genes in human primary liver tumors with beta-catenin mutations. Oncogene (2006) 1.24

Diphencyprone in the treatment of alopecia areata. Acta Derm Venereol (1983) 1.24

[Atrophodermia linearis Moulin. A new disease picture, following the Blaschko lines]. Hautarzt (1994) 1.22

Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity. Oncogene (1999) 1.22

Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada. Int J Pancreatol (1992) 1.21

Electron microscopical evidence for a direct contact between nerve fibres and mast cells. Acta Derm Venereol (1981) 1.15

Dinitrochlorobenzene therapy for alopecia areata. Arch Dermatol (1978) 1.15

Acrodermatitis acidemica secondary to malnutrition in glutaric aciduria type I. Eur J Dermatol (2001) 1.14

Large aberrant Mongolian spots coexisting with cutis marmorata telangiectatica congenita (phacomatosis pigmentovascularis type V or phacomatosis cesiomarmorata). J Eur Acad Dermatol Venereol (2006) 1.12

Fatal cardiac arrhythmias and shock following yew leaves ingestion. Ann Emerg Med (1987) 1.11

X-linked dominant chondrodysplasia punctata. Review of literature and report of a case. Hum Genet (1979) 1.10

Manifestation of the lines of Blaschko in women heterozygous for X-linked hypohidrotic ectodermal dysplasia. Clin Genet (1985) 1.09

Effect of age and role of kidneys and liver on thyrotropin turnover in man. Metabolism (1974) 1.08

Cross-species characterization of the promoter region of the cystic fibrosis transmembrane conductance regulator gene reveals multiple levels of regulation. Biochem J (1997) 1.07

[How are the Blaschko lines arranged on the scalp?]. Hautarzt (1984) 1.07

Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations. J Pathol (2007) 1.07

Linear verrucous hemangioma. J Am Acad Dermatol (2000) 1.06

Plasma levels of tumor necrosis factor in the adult respiratory distress syndrome. Am Rev Respir Dis (1991) 1.06

Centrally generated pattern of motoneuron activity during locomotion in the cat. Symp Soc Exp Biol (1983) 1.05

Food habits and pancreatic cancer: a case-control study of the Francophone community in Montreal, Canada. Cancer Epidemiol Biomarkers Prev (1995) 1.04

Haemodynamics in phaeochromocytoma. A report of 2 cases. Intensive Care Med (1979) 1.03

Coexisting linear and disseminated drug eruption: a clinical clue to the understanding of the genetic basis of drug eruptions. Eur J Dermatol (2001) 1.03

Abnormal expression of class I and class II major histocompatibility antigens in alopecia areata: modulation by topical immunotherapy. J Invest Dermatol (1987) 1.02

Two cases of type 2 segmental manifestation in a family with cutaneous leiomyomatosis. Eur J Dermatol (2000) 1.02

Inflammatory linear verrucous epidermal nevus (ILVEN) in a mother and her daughter. Am J Med Genet (1986) 1.02

Antigenic competition as a therapeutic concept for alopecia areata. Arch Dermatol Res (1980) 1.02

cis-Acting elements and transcription factors involved in the intestinal specific expression of the rat calbindin-D9K gene: binding of the intestine-specific transcription factor Cdx-2 to the TATA box. Eur J Biochem (1996) 1.01

Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice. Cancer Res (1999) 1.01

Arguments in favor of a polygenic inheritance of precursor nevi. J Am Acad Dermatol (1982) 1.01

HID and KID syndromes are associated with the same connexin 26 mutation. Br J Dermatol (2002) 1.01

[Pincer nail. Conservative correction by attachment of a plastic brace]. Hautarzt (1993) 1.01

Klippel-Trenaunay syndrome: is it a paradominant trait? Br J Dermatol (1993) 1.01

Topical immunotherapy changes the composition of the peribulbar infiltrate in alopecia areata. Arch Dermatol Res (1986) 1.00

Phacomatosis pigmentokeratotica: report of new cases and further delineation of the syndrome. Arch Dermatol (1998) 1.00

[Alopecia areata: successful half-side treatment with DNCB]. Z Hautkr (1977) 1.00

Evidence of static and dynamic fusimotor actions on the spindle response to sinusoidal stretch during locomotor activity in the cat. Exp Brain Res (1973) 0.99

Cardiac arrest: prognostic factors and outcome at one year. Resuscitation (1993) 0.99

Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene-environment interactions. Int J Cancer (2001) 0.99

Autosomal dominant lamellar ichthyosis: a new skin disorder. Clin Genet (1984) 0.98

Transcriptional and post-transcriptional regulation of vitamin D-dependent calcium-binding protein gene expression in the rat duodenum by 1,25-dihydroxycholecalciferol. J Biol Chem (1987) 0.98

Cigarette smoking as a triggering factor of hidradenitis suppurativa. Dermatology (1999) 0.98

Cutaneous leiomyomatosis with type 2 segmental involvement. J Dermatol (2001) 0.98

Ichthyosis bullosa of Siemens: a unique type of epidermolytic hyperkeratosis. J Am Acad Dermatol (1986) 0.98

Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenic mice. Am J Physiol (1999) 0.97

A case-control study of toenail selenium and cancer of the breast, colon, and prostate. Cancer Detect Prev (2000) 0.97

Cutaneous manifestations of methylmalonic acidemia. Arch Dermatol Res (1990) 0.97

Microsatellite variation and structure of 28 populations of the common wetland plant, Lychnis flos-cuculi L., in a fragmented landscape. Mol Ecol (2005) 0.97

Entrainment of the spinal pattern generators for swimming by mechano-sensitive elements in the lamprey spinal cord in vitro. Brain Res (1981) 0.96

Linear atrophoderma of Moulin. Eur J Dermatol (2000) 0.96

Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1. Oncogene (2011) 0.96

Striation of bones in focal dermal hypoplasia: manifestation of functional mosaicism? Br J Dermatol (1977) 0.96

Current understanding of androgenetic alopecia. Part I: etiopathogenesis. Eur J Dermatol (2000) 0.96

Mutational spectrum of NSDHL in CHILD syndrome. J Med Genet (2005) 0.95

Trichinella in horses: a low frequency infection with high human risk. Vet Parasitol (2000) 0.95

Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study. J Crit Care (1997) 0.95

The reliability of recollections of family history: implications for the medical provider. J Cancer Educ (1997) 0.95

Multiple agminate Spitz naevi: review of the literature and report of a case with distinctive immunohistological features. Br J Dermatol (1987) 0.94

Homologous genes for X-linked chondrodysplasia punctata in man and mouse. Hum Genet (1983) 0.94

Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis. Lupus (1997) 0.94

Tenascin expression in hyperproliferative skin diseases. Br J Dermatol (1991) 0.94

[Becker nevus syndrome]. Actas Dermosifiliogr (2007) 0.94